a
a
Weather:
No weather information available
HomeHealthPivotal VALIANT results presented at Kidney Week show pegcetacoplan treatment effect in patients with C3G / primary IC-MPGN

Pivotal VALIANT results presented at Kidney Week show pegcetacoplan treatment effect in patients with C3G / primary IC-MPGN

Statistically significant 68% (p

No comments

Sorry, the comment form is closed at this time.

Translate »